VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration (AMD), today announced the U.S. Food and Drug Administration approved the Implantable Miniature Telescope (by Dr. Isaac Lipshitz) for use in patients living with bilateral end-stage age-related macular degeneration who are age 65 or older. The telescope implant is the only FDA approved surgical device for end-stage AMD and is Medicare eligible.
Just look into the light: not quite, but researchers at the UC Davis Center for Neuroscience and Department of Psychology have used light to erase specific memories in mice, and proved a basic theory of how different parts of the brain work together to retrieve episodic memories.
Vikram Kodibagkar’s progress in engineering tools and techniques to more precisely reveal the condition of body tissues, specifically tissue oxygen levels, has earned support for his research from the National Science Foundation (NSF).
Melanoma is the fifth most common cancer type in the United States, and it's also the deadliest form of skin cancer, causing more than 75 percent of skin-cancer deaths. If caught early enough though, it is almost always curable.
The CAO Group, Inc. (CAO), a world leading high technology company, has been granted its third patent (US Pat. No. 8,834,457) by the United States Patent Office regarding its medical diode laser systems. This patent provides protection of CAO’s innovative methods to deliver laser energy through a disposable tip.
Inspired by a desire to help wounded soldiers, an international, multidisciplinary team of researchers led by Assistant Professor Conor L. Evans at the Wellman Center for Photomedicine of Massachusetts General Hospital (MGH) and Harvard Medical School (HMS) has created a paint-on, see-through, "smart" bandage that glows to indicate a wound's tissue oxygenation concentration.
The clinical study of the iGrow® Hair Growth System titled “The growth of human scalp hair in females using visible red light laser and LED sources” is featured in the October 2014 issue of Lasers in Surgery and Medicine, considered the gold standard journal on laser-based technology.
CANCER RESEARCH UK’s Centre for Drug Development (CDD), in collaboration with the Rising Tide Foundation, a Swiss-based non-profit organisation which funds innovative cancer trials, today (TUESDAY) announce a new trial at The Royal Marsden and University College London that could revolutionise how children with one of the deadliest forms of cancer are diagnosed. The news falls in Children’s Cancer Awareness Month, which runs throughout September.
A technique developed by astronomers seeking a clear view of distant objects in space is being intensively studied as a new approach to measuring and correcting visual abnormalities. The October issue of Optometry and Vision Science, official journal of the American Academy of Optometry, is a theme issue devoted to research on wavefront refraction and correction. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
AdvancedCath, a portfolio company of Inverness Graham Investments, announced on September 9, 2014 it significantly expanded its outsourced medical device manufacturing platform by acquiring LSA Laser located in Plymouth, MN. LSA Laser brings state of the art laser welding and micro machining capabilities to complement AdvancedCath’s existing catheter and guidewire manufacturing business.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.